Experts from the National Autonomous University of Mexico (UNAM) have detailed the risks posed by the antibiotic-resistant bacterium Acinetobacter baumannii [1].
The pathogen's ability to withstand multiple medical treatments makes it a critical health threat to patients in hospital settings. Because the bacterium can develop resistance to various antibiotics, infections become difficult to treat, increasing the risk of mortality for vulnerable patients [1], [2].
Santiago Castillo Ramírez, a researcher at UNAM's Centro de Ciencias Genómicas, said the nature of this "super-bacteria" and why the World Health Organization (WHO) has classified it as a critical pathogen [1]. The bacterium primarily affects patients within hospitals in Mexico City and other regions, where it can spread in clinical environments [2].
According to the researchers, the primary danger lies in the organism's adaptability. Acinetobacter baumannii can survive on surfaces and resist the standard pharmaceutical interventions used to combat respiratory and bloodstream infections [1]. The WHO's classification serves as a global alert to healthcare systems to improve sterilization, and surveillance protocols [2].
UNAM's analysis emphasizes that the rise of such pathogens is often linked to the overuse of antibiotics in medical practice. This evolutionary pressure allows bacteria to develop defense mechanisms that render common drugs ineffective [1]. Researchers said the focus must remain on identifying these strains early to prevent outbreaks within healthcare facilities [2].
“The bacterium primarily affects patients within hospitals in Mexico City.”
The identification of Acinetobacter baumannii as a critical threat underscores a growing global crisis of antimicrobial resistance. When common bacteria evolve to survive standard antibiotics, routine medical procedures—such as surgeries or ventilator use—become significantly more dangerous. The focus on Mexican hospitals suggests a need for stricter infection control and a shift in how antibiotics are prescribed to prevent the further evolution of superbugs.
